Publication Cover
Reproductive Health Matters
An international journal on sexual and reproductive health and rights
Volume 16, 2008 - Issue 32: Reproductive cancers
2,130
Views
42
CrossRef citations to date
0
Altmetric
Original Articles

Making the case for cervical cancer prevention: what about equity?

&
Pages 104-112 | Published online: 21 Nov 2008

References

  • MA Gonzalez Block, P Sandiford, JA Ruiz. Beyond health gain: the range of health system benefits expressed by social groups in Mexico and Central America. Social Science and Medicine. 52(10): 2001; 1537–1550.
  • DR Gwatkin. Health inequalities and the health of the poor: what do we know? What can we do?. Bulletin of World Health Organization. 78(1): 2000; 3–18.
  • ME Kruk, LP Freedman. Assessing health system performance in developing countries: a review of the literature. Health Policy. 85(3): 2008; 263–276.
  • M Whitehead, G Dahlgren, D McIntyre. Putting equity center stage: challenging evidence-free reforms. International Journal of Health Services. 37(2): 2007; 353–361.
  • AM Dans, L Dans, AD Oxman. Assessing equity in clinical practice guidelines. Journal of Clinical Epidemiology. 60(6): 2007; 540–546.
  • M Whitehead. The Concepts and Principles of Equity and Health. EUR/ICP/RPD 414. 1990; World Health Organization Regional Office for Europe: Copenhagen.
  • P Braveman. Health disparities and health equity: concepts and measurement. Annual Review of Public Health. 27(1): 2006; 167–194.
  • DR Gwatkin. 10 best resources on … health equity. Health Policy and Planning. 22(5): 2007; 348–351.
  • P Braveman, S Gruskin. Defining equity in health. Journal of Epidemiology and Community Health. 57(4): 2003; 254–258.
  • DM Parkin, F Bray. Chapter 2: The burden of HPV-related cancers. Vaccine. 21(24 Suppl 3): 2006; S11–S25.
  • Ferlay J, Bray F, Pisani P, et al. Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide. [Version 2.0]. 2004. Lyon: IARC Press. IARC CancerBase No. 5.
  • HC Kitchener, PE Castle, JT Cox. Chapter 7: Achievements and limitations of cervical cytology screening. Vaccine. 21(24 Suppl 3): 2006; S63–S70.
  • R Sankaranarayanan, J Ferlay. Worldwide burden of gynaecological cancer: the size of the problem. Best Practice and Research. Clinical Obstetrics & Gynaecology. 20(2): 2006; 207–225.
  • LS Palacio-Mejia, G Rangel-Gomez, M Hernandez-Avila. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Pública de México. 45(Suppl 3): 2003; S315–S325.
  • ED O’Brien, RS Bailie, PL Jelfs. Cervical cancer mortality in Australia: contrasting risk by aboriginality, age and rurality. International Journal of Epidemiology. 29(5): 2000; 813–816.
  • J Bradley, M Barone, C Mahe. Delivering cervical cancer prevention services in low-resource settings. International Journal of Gynecology and Obstetrics. 89(Suppl 2): 2005; S21–S29.
  • L Denny, M Quinn, R Sankaranarayanan. Chapter 8: Screening for cervical cancer in developing countries. Vaccine. 24(Suppl 3): 2006; S71–S77.
  • DR Gwatkin, A Bhuiya, CG Victora. Making health systems more equitable. Lancet. 364(9441): 2004; 1273–1280.
  • P Braveman, E Tarimo. Social inequalities in health within countries: not only an issue for affluent nations. Social Science and Medicine. 54(11): 2002; 1621–1635.
  • L Bogg, D Hengjin, K Wang. The cost of coverage: rural health insurance in China. Health Policy and Planning. 11(3): 1996; 238–252.
  • JM Msuya, CN Nyaruhucha, J Kaswahili. Does preventive health care have a chance in the changing health sector in Tanzania?. East African Medical Journal. 80(3): 2003; 135–139.
  • E Delamonica, A Minujin, J Gulaid. Monitoring equity in immunization coverage. Bulletin of World Health Organization. 83(5): 2005; 384–391.
  • UNICEF. Progress for Children: A World Fit for Children. Statistical Review. No.6. 2007; UNICEF: New York.
  • R Horton. Chronic diseases: the case for urgent global action. Lancet. 370(9603): 2007; 1881–1882.
  • C Elias, J Sherris. Reproductive and sexual health of older women in developing countries. BMJ (Clinical Research ed.). 327(7406): 2003; 64–65.
  • J Shiffman. Has donor prioritization of HIV/AIDS displaced aid for other health issues?. Health Policy and Planning. 23(2): 2008; 95–100.
  • SW Sinding. Keeping sexual and reproductive health at the forefront of global efforts to reduce poverty. Studies in Family Planning. 36(2): 2005; 140–143.
  • A Ahmed, R Vargas Hill, L Smith. The World’s Most Deprived: Characteristics and Causes of Extreme Poverty and Hunger. Report No.2020. Discussion Paper 43. 2007; International Food Policy Research Institute: Washington DC.
  • DB Huong, NK Phuong, S Bales. Rural health care in Vietnam and China: conflict between market reforms and social need. International Journal of Health Services. 37(3): 2007; 555–572.
  • F Castro-Leal, J Dayton, L Demery. Public spending on health care in Africa: do the poor benefit?. Bulletin of World Health Organization. 78(1): 2000; 66–74.
  • D McIntyre, M Thiede, G Dahlgren. What are the economic consequences for households of illness and of paying for health care in low-and middle-income country contexts?. Social Science and Medicine. 62(4): 2006; 858–865.
  • PS Houts, A Lipton, HA Harvey. Nonmedical costs to patients and their families associated with outpatient chemotherapy. Cancer. 53(11): 1984; 2388–2392.
  • M Stommel, CW Given, BA Given. The cost of cancer home care to families. Cancer. 71(5): 1993; 1867–1874.
  • JU Ohaeri, OB Campbell, AO Ilesanmi. The psychosocial burden of caring for some Nigerian women with breast cancer and cervical cancer. Social Science and Medicine. 49(11): 1999; 1541–1549.
  • M Chen, J Vanek, F Lund. Progress of the World’s Women 2005: Women, Work and Poverty. 2005; United Nations Development Fund for Women: New York.
  • A Iyer, G Sen, A George. The dynamics of gender and class in access to health care: evidence from rural Karnataka, India. International Journal of Health Services. 37(3): 2007; 537–554.
  • A Bingham, A Bishop, P Coffey. Factors affecting utilization of cervical cancer prevention services in low-resource settings. Salud Pública de México. 45(Suppl 3): 2003; S408–S416.
  • I Agurto, S Arrossi, S White. Involving the community in cervical cancer prevention programs. International Journal of Gynecology and Obstetrics. 89(Suppl 2): 2005; S38–S45.
  • J Knodel, S Watkins, M VanLandingham. AIDS and older persons: an international perspective. Journal of Acquired Immune Deficiency Syndrome. 33(Suppl 2): 2003; S153–S165.
  • UNAIDS. 2004 Report on the Global AIDS Epidemic. 4th Global Report. 2004; UNAIDS: Geneva.
  • EJ Schatz. “Taking care of my own blood”: older women’s relationships to their households in rural South Africa. Scandinavian Journal of Public Health. 69(Suppl): 2007; 147–154.
  • World Bank. A New Agenda for Women’s Health and Nutrition. 1994; World Bank: Washington DC.
  • CE Levin, MT Ruel, SS Morris. Working women in urban settings: traders, vendors, and food security in Accra. World Development. 27(11): 1999; 1977–1991.
  • UN Food and Agriculture Organization. Women and food security. FAO Focus March 1997. At: <www.fao.org/FOCUS/E/Women/Sustin-e.htm. >. Accessed 3 March 2008.
  • UN Population Fund. Food for the Future: Women, Population, and Food Security. 1996; UNFPA: New York.
  • R Sankaranarayanan, L Gaffikin, M Jacob. A critical assessment of screening methods for cervical neoplasia. International Journal of Gynecology and Obstetrics. 89(Suppl 2): 2005; S4–S12.
  • R Sankaranarayanan, R Rajkumar, PO Esmy. Effectiveness, safety and acceptability of ‘see and treat’ with cryotherapy by nurses in a cervical screening study in India. British Journal of Cancer. 96(5): 2007; 738–743.
  • R Sankaranarayanan, PO Esmy, R Rajkumar. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 370(9585): 2007; 398–406.
  • PATH. Innovation in biochemical cervical cancer screening. November. 2007; PATH: Seattle. At: <www.path.org/files/RH_start_biochem_scr_fs_en.pdf. >. Accessed 10 March 2007.
  • SJ Goldie, L Gaffikin, JD Goldhaber-Fiebert. Cost-effectiveness of cervical cancer screening in five developing countries. New England Journal of Medicine. 353(20): 2005; 2158–2168.
  • J Winkler, A Bingham, P Coffey. Women’s participation in a cervical cancer screening program in northern Peru. Health Education Research. 23(1): 2008; 10–24.
  • KA Ault. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet. 369(9576): 2007; 1861–1868.
  • J Paavonen, D Jenkins, FX Bosch. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 369(9580): 2007; 2161–2170.
  • A Hildesheim, R Herrero, S Wacholder. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 298(7): 2007; 743–753.
  • R Winer, Q Feng, J Hughes. Risk of female human papillomavirus acquisition associated with first male sex partner. Journal of Infectious Diseases. 197(2): 2008; 279–282.
  • JA Kahn, RD Burk. Papillomavirus vaccines in perspective. Lancet. 369(9580): 2007; 2135–2137.
  • FT Cutts, S Franceschi, S Goldie. Human papillomavirus and HPV vaccines: a review. Bulletin of World Health Organization. 85(9): 2007; 719–726.
  • UNICEF. State of the World’s Children 2008. 2008; UNICEF: New York.
  • FE Andre, R Booy, HL Bock. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bulletin of World Health Organization. 86(2): 2008; 140–146.
  • LaMontagne DS, Bingham A, Katahoire A, et al. HPV vaccine implementation in developing countries: understanding the socio-cultural context, health systems environment and policy landscape for successful vaccine delivery. Presented at: 24th International Papillomavirus Conference, Beijing, 7 November 2007.
  • Instituto de Investigación Nutricional. Strategies for the Introduction of the Human Papillomavirus (HPV) Vaccine for the Prevention of Cervical Cancer: Final Report to PATH. 2008; Instituto de Investigación Nutricional: Lima. (Forthcoming).
  • RT Mahoney, JE Maynard. The introduction of new vaccines into developing countries. Vaccine. 17(7–8): 1999; 646–652.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.